Keratin 17 (KRT17) Peptide
Our Local Distributor
北京 101111
Quick Overview for Keratin 17 (KRT17) Peptide (ABIN939286)
抗原
宿主
资源
应用范围
-
-
蛋白类型
- Synthetic
-
序列
- IATYRRLLEG EDAHLTQYKK EPVTTRQVRT IVEEVQDGKV ISSREQVHQT
-
产品特性
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KRT17 antibody,
Alternative Names: Cytokeratin 17 control peptide, Cytokeratin 17 antibody Blocking Peptide, Anti-Cytokeratin 17 Blocking Peptide, Keratin 17 Blocking Peptide, K17 Blocking Peptide, PC Blocking Peptide, PC2 Blocking Peptide, PCHC1 Blocking Peptide, KRT17 Blocking Peptide, Cytokeratin 17, Cytokeratin -17, Cytokeratin 17, Cytokeratin -17 Blocking Peptide, Cytokeratin 17 Blocking Peptide
-
-
-
-
应用备注
- Optimal conditions should be determined by the investigator
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
缓冲液
- PBS
-
注意事项
- Avoid repeated freeze/thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- Store at -20 °C long term.
-
-
- KRT17 (Keratin 17 (KRT17))
-
背景
- KRT17 is type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in its gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.KRT17 encodes the type I intermediate filament chain keratin 17, expressed in nail bed, hair follicle, sebaceous glands, and other epidermal appendages. Mutations in this gene lead to Jackson-Lawler type pachyonychia congenita and steatocystoma multiplex.
-
分子量
- 48 kDa
抗原
-